NOV 19, 2016 12:18 PM PST

CRISPR Tested in Humans for the First Time

WRITTEN BY: Xuan Pham

In a historic, landmark clinical trial, Chinese researchers injected a patient with a shot of CRISPR-edited white blood cells in an effort to treat cancer.
 

Image credit: Pixabay.com


During the past few years, the CRISPR craze has taken hold of the scientific community, and it shows no signs of letting go. Due to its relatively low cost and high efficiency, CRISPR is revolutionizing the gene-editing game. Many of the breakthroughs using this technology are aimed at improving human health and curing diseases. But none so far has gone as far as using the technology in a human clinical trial.
 
The Chinese trial enrolled 10 participants who are diagnosed with metastatic non-small cell lung cancer. Because their cancer is advanced and has spread to other parts of the body, the patients have shown no signs of positive response to current available treatments. Their life expectancy is grim at only 6 months. In this context, the CRISPR technique may be the only tool left that can give these patients some hope.
 
To help these patients, Chinese researchers exploited the cut-and-paste mechanism of CRISPR to modify the patient’s own immune response cells. In particular, the team isolated the patients’ T cells – a type of white blood cell – to which they modified with CRISPR. The modification turns off a gene responsible for programmed cell death (PD-1). Scientists hope that with this switch off, the T cells can be unleashed to destroy cancer cells in the patients.
 


In essence, it’s a modernized version of immunotherapy – using the patient’s own immune system to combat the cancer invasion. The hope is that the patient’s cells will be much more adept at killing cancer than foreign drug compounds. Furthermore, this method should also minimize the risks to the patient’s healthy cells.
 
The injection was given to the patient as part of a Phase 1 trial, which means that scientists are trying to answer the question of the treatment’s safety. Results from this trial should inform us on how human bodies actually received CRISPR-edited cells and whether there are any unwanted side effects from this treatment. Whether the CRISPR-modified treatment will cure cancer will probably not be answered until years from now.
 
For now, the scientific community may receive this news with mixed reactions. While some may hail this as an exciting step towards genome engineering for human diseases, others are concerned that CRISPR will open the door for unethical tampering of the human genome (think designer babies). However, CRISPR seems unstoppable, and the US is also expected to approve its own medical trials with this technology soon too. 
 


Additional sources: Popular Science, Nature

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JAN 14, 2020
Clinical & Molecular DX
JAN 14, 2020
Can I eat this donut? A quick test for celiac disease.
Genetic testing revealed that our ancestors have been eating wheat, rye, spelt and barley for over 8,000 years. Today, g ...
FEB 19, 2020
Clinical & Molecular DX
FEB 19, 2020
Forget complicated scans - ovarian cancer can be detected in the blood
Results from clinical trials performed in Melbourne, Australia have revealed the diagnostic potential of a new test for ...
FEB 19, 2020
Immunology
FEB 19, 2020
Testing the Immune Response to Ovarian Cancer Treatment
There is a new diagnostic test for the deadliest form of gynecological cancer – ovarian cancer. Better tests mean ...
JUN 11, 2020
Clinical & Molecular DX
JUN 11, 2020
Glowing Chemical Reactions Could Put an End to Bad COVID Tests
  Advancements in diagnostic technologies are paving the way for the next generation of ultra-sensitive serological ...
JUN 29, 2020
Cancer
JUN 29, 2020
Mass Spectrometry and How It Can Profile Cancer
Treatments for cancer usually revolve around targeting certain immune checkpoints in the cell. Protein cell death protei ...
JUN 30, 2020
Cardiology
JUN 30, 2020
Investigating How Aging Affects Cardiac Health in Marmosets
Age is something that scientists still struggle to understand. It seems to be built into the DNA and affects the human b ...
Loading Comments...